Followers | 612 |
Posts | 26869 |
Boards Moderated | 1 |
Alias Born | 08/12/2010 |

Wednesday, June 18, 2025 11:23:08 AM
And Dateline plans to create their own operation to process the elements to finished product, essentially become a competitor. Would you JV with them or even process a toll with them if their end goal is to compete directly with them. $MP has spent years developing the technology and capability. The elements will get to $mp. Like I stated before, either close by or even from Greenland. $MP is going to work with the Saudi's as well.
All I am saying is $dtref doesn't even have funding from the Federal Govt. Seems strange to me. All the early hype. Windows open and Windows close is all that I am saying.
To demand NO JV and 5$ price tags is a stretch. Maybe there is more to this story that we do not know.
I am pulling for Dateline👍️
ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM